Most of us use some Johnson & Johnson products at all times in our day-to-day operations. Tylenol, Band-Aid, Motrin, and Listerine are some of the branded products presented by Johnson and Johnson (JNJ). As a result of the efficiency of the building and the retention of the name that has been named, the JNJ is a very important asset retention. Fortunately, for shareholders, it has worked well in the last quarter century. In fact, $ 10,000 was invested in Johnson & Johnson in early 1975 to more than $ 391,000 at the end of 2006, not including any other decisions or interventions that have occurred.
Since 1975, Johnson & Johnson has been back 22 years and 10 years for negative returns. The best return years for JNJ assets were 1991, 1995, and 1985, with 60%, 56%, and 46% respectively. However, the worst working years for JNJ assets were 1983, 1976, and 1993, with 18%, 13%, and 12% mortality. The growth of Johnson & Johnson assets over the past quarter century resulted in five shares, the last of which was 2 for 1 in June 2001.
Johnson & Johnson is one of 30 stocks riding the Dow Jones Industrial Average (DJIA). However, JNJ’s annual returns have not been fully linked to all DJIA movements and other stocks of the index that have a target. For example, General Electric (GE), has moved in the same direction as the Dow Jones almost 94% of the time since 1975. Johnson & Johnson, on the other hand, have moved in the same direction as DJIA less than 72% of the time in the same period. Indeed, 9 of the 32 years since 1975, JNJ has moved forward for the entire Dow Jones Industrial Average. The way forward is to expect Johnson & Johnson to grow in the future, as the use of its popular brand name products and population continues to grow. Yes, like all things, be diligent in your actions before you make an investment decision.